Scarica l'app Stockscreener
252.89
2.41%
5.96
Pre-mercato:
252.50
-0.39
-0.15%
Precedente Chiudi:
$246.93
Aprire:
$248.32
Volume 24 ore:
444.43K
Relative Volume:
1.26
Capitalizzazione di mercato:
$9.71B
Reddito:
$1.16B
Utile/perdita netta:
$34.55M
Rapporto P/E:
294.06
EPS:
0.86
Flusso di cassa netto:
$134.18M
1 W Prestazione:
+0.26%
1M Prestazione:
+2.99%
6M Prestazione:
+32.52%
1 anno Prestazione:
-2.13%
Intervallo 1D:
$245.27
$254.00
Intervallo di 1 settimana:
$237.65
$258.52
Portata 52W:
$148.00
$277.34
Penumbra Inc Stock (PEN) Company Profile
Nome
Penumbra Inc
Settore
Industria
Telefono
(510) 995-2486
Indirizzo
ONE PENUMBRA PLACE, ALAMEDA, CA
Confronta PEN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PEN
Penumbra Inc
|
252.89 | 9.71B | 1.16B | 34.55M | 134.18M | 0.86 |
|
ABT
Abbott Laboratories
|
113.02 | 196.03B | 41.22B | 5.77B | 6.49B | 3.29 |
|
BSX
Boston Scientific Corp
|
95.65 | 140.97B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
362.80 | 138.31B | 21.97B | 3.59B | 3.21B | 9.33 |
|
MDT
Medtronic Plc
|
85.25 | 109.31B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
71.04 | 41.90B | 6.60B | 4.16B | 490.10M | 6.93 |
Penumbra Inc Stock (PEN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-17 | Iniziato | Oppenheimer | Outperform |
| 2024-12-11 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-09-18 | Iniziato | Stifel | Buy |
| 2024-09-03 | Iniziato | Leerink Partners | Outperform |
| 2024-07-31 | Downgrade | Citigroup | Buy → Neutral |
| 2024-07-31 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-02-23 | Downgrade | JP Morgan | Overweight → Neutral |
| 2023-09-06 | Iniziato | Morgan Stanley | Equal-Weight |
| 2023-07-19 | Iniziato | Robert W. Baird | Outperform |
| 2023-03-29 | Downgrade | Needham | Buy → Hold |
| 2023-01-30 | Iniziato | Piper Sandler | Overweight |
| 2022-11-04 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-10-12 | Iniziato | Jefferies | Buy |
| 2022-10-05 | Downgrade | Citigroup | Buy → Neutral |
| 2022-09-09 | Aggiornamento | Needham | Hold → Buy |
| 2022-07-18 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-04-19 | Iniziato | Deutsche Bank | Buy |
| 2022-03-08 | Iniziato | Needham | Hold |
| 2021-09-16 | Iniziato | Truist | Buy |
| 2021-06-04 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2020-12-16 | Downgrade | BTIG Research | Buy → Neutral |
| 2020-10-07 | Ripresa | Canaccord Genuity | Buy |
| 2020-09-29 | Iniziato | BTIG Research | Buy |
| 2020-09-08 | Downgrade | BofA Securities | Buy → Neutral |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2019-06-13 | Reiterato | BofA/Merrill | Buy |
| 2019-05-30 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2019-05-21 | Iniziato | William Blair | Outperform |
| 2018-10-29 | Ripresa | BofA/Merrill | Buy |
| 2018-10-08 | Iniziato | RBC Capital Mkts | Outperform |
| 2018-02-21 | Iniziato | William Blair | Outperform |
| 2018-01-02 | Downgrade | JP Morgan | Overweight → Neutral |
| 2015-11-30 | Reiterato | Canaccord Genuity | Buy |
| 2015-10-13 | Iniziato | Wells Fargo | Outperform |
Mostra tutto
Penumbra Inc Borsa (PEN) Ultime notizie
Aneurysm Coiling and Embolization Devices Market to Grow by USD 2.0 Billion from 2025-2029, Driven by Rising IAS Cases and AI-Powered Market EvolutionTechnavio - The Malaysian Reserve
Penumbra (PEN) Surges 6.3%: Is This an Indication of Further Gains? - MSN
Penumbra, Inc. to Present at the 43rd Annual J.P. Morgan Healthcare Conference - Kilgore News Herald
Penumbra stock rises following Stryker's Inari Medical acquisition By Investing.com - Investing.com South Africa
Penumbra stock rises following Stryker's Inari Medical acquisition - Investing.com India
Penumbra stock rises following Stryker’s Inari Medical acquisition By Investing.com - Investing.com Nigeria
Penumbra spikes after Stryker- Inari deal - MSN
Penumbra (NYSE:PEN) Trading 7.1% HigherStill a Buy? - MarketBeat
Insider Sell: Harpreet Grewal Sells Shares of Penumbra Inc (PEN) - GuruFocus.com
Penumbra stock gains after Stryker- Inari deal (NARI:NASDAQ) - Seeking Alpha
Penumbra: Re-Rated For The Wrong Reasons (NYSE:PEN) - Seeking Alpha
Reasons to Add Penumbra Stock to Your Portfolio Now - MSN
Insider Selling: Penumbra, Inc. (NYSE:PEN) Director Sells 167 Shares of Stock - MarketBeat
Penumbra (NYSE:PEN) Sees Unusually-High Trading VolumeHere's What Happened - MarketBeat
Capital Allocation Trends At Penumbra (NYSE:PEN) Aren't Ideal - Yahoo Finance
Investors Appear Satisfied With Penumbra, Inc.'s (NYSE:PEN) Prospects - Simply Wall St
Penumbra to Present at J.P. Morgan Healthcare Conference 2025: Key Investor Event Ahead - StockTitan
Penumbra Inc.: An Insight Into Its Margin Expansion Opportunities & Other Major Drivers - Smartkarma
Penumbra, Inc. (NYSE:PEN) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Is Penumbra (PEN) a Solid Growth Stock? 3 Reasons to Think "Yes" - MSN
Principal Financial Group Inc. Has $17.62 Million Holdings in Penumbra, Inc. (NYSE:PEN) - MarketBeat
(PEN)Analyzing Penumbra's Short Interest - Benzinga
Penumbra, Inc. (NYSE:PEN) CEO Adam Elsesser Sells 15,000 Shares - MarketBeat
Penumbra CEO Adam Elsesser sells $3.64 million in stock By Investing.com - Investing.com Australia
Penumbra CEO Adam Elsesser sells $3.64 million in stock - Investing.com India
Here's Why Penumbra (PEN) is a Strong Growth Stock - Yahoo Finance
Penumbra, Inc. (NYSE:PEN) Shares Purchased by Barclays PLC - MarketBeat
Penumbra Launches Lightning Flash 2.0Latest CAVT Technology D - GuruFocus.com
Penumbra price target raised to $285 from $240 at Truist - Yahoo Finance
Penumbra Receives CE Mark for Computer Assisted Vacuum Thrombectomy TechnologiesLightning Flash™ 2.0 and Lightning Bolt™ 7in Europe - The Eastern Progress Online
Y Intercept Hong Kong Ltd Cuts Holdings in Penumbra, Inc. (NYSE:PEN) - MarketBeat
Interventional Neurology Market Is Booming Worldwide - openPR
Penumbra's SWOT analysis: innovation drives growth amid market challenges - Investing.com India
Penumbra's SWOT analysis: innovation drives growth amid market challenges By Investing.com - Investing.com Canada
Penumbra (NYSE:PEN) Stock Price Expected to Rise, Truist Financial Analyst Says - MarketBeat
Here's Why Penumbra (PEN) is a Strong Momentum Stock - Yahoo Finance
Geode Capital Management LLC Purchases 11,257 Shares of Penumbra, Inc. (NYSE:PEN) - MarketBeat
Penumbra Is Poised For Growth As Blood Clot Awareness Rises: Analyst - Benzinga
Oppenheimer Initiates Coverage on Penumbra (NYSE:PEN) - MarketBeat
Oppenheimer Initiates Coverage of Penumbra (PEN) with Outperform Recommendation - Nasdaq
Franklin Resources Inc. Increases Stake in Penumbra, Inc. (NYSE:PEN) - MarketBeat
Wilmington Savings Fund Society FSB Makes New $7 Million Investment in Penumbra, Inc. (NYSE:PEN) - MarketBeat
State Street Corp Purchases 3,863 Shares of Penumbra, Inc. (NYSE:PEN) - MarketBeat
BNP Paribas Financial Markets Lowers Stake in Penumbra, Inc. (NYSE:PEN) - MarketBeat
Penumbra Inc Azioni (PEN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.10%
0.74%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):